Histogen
在场
Histogen 是一家在股票代码 HSTO (US) 下上市的公司。
涉及Histogen的并购和融资。
- Histogen has filed for bankruptcy protection (公布2024四月19号).
高管
查看带有其 9 名主要高管的组织结构图
Histogen 搜索最多的简介
高管在Histogen变化
- Steven Mento, Executive Chairman and Interim President and Chief Executive Officer, 将于 20239月30 退休 (新闻发布的2023九月22号).
- Susan Knudson 曾任 Executive Vice President, Chief Operating Officer and Chief Financial Officer, 将于 202310月1 升职为 Chief Executive Officer, Chief Financial Officer, Secretary and Principal Financial Officer (新闻发布的2023九月22号).
创建提醒
跟踪 Histogen 的高管变动
生物技术
Histogen 拥有 2,282 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Endeavor BioMedicines 刚刚宣布为 132 筹款数百万美元。 (公布2024四月25号).
- Metsera 刚刚宣布为 290 筹款数百万美元。 (公布2024四月23号).
- Histogen has filed for bankruptcy protection (公布2024四月19号).
生物技术 行业的其他推荐联系人
消息
Histogen 的最新新闻稿
- Histogen to Report Second Quarter 2022 Financial Results and Provide Business Update | Histogen, Inc.
- Histogen Announces Closing of $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules | Histogen, Inc.
- Histogen Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules | Histogen, Inc.
- Histogen Announces 1-for-20 Reverse Stock Split | Histogen, Inc.
- Histogen to Present at the H.C. Wainwright Global Investment Conference | Histogen, Inc.
- Histogen Reports First Quarter 2022 Financial Results and Provides Business Update | Histogen, Inc.
- Histogen to Report First Quarter 2022 Financial Results and Provide Business Update | Histogen, Inc.
- Histogen Announces Closing of $4.75 Million Private Placement | Histogen, Inc.
- Histogen Announces $4.75 Million Private Placement | Histogen, Inc.
- Histogen Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update | Histogen, Inc.
- View more press releases Close
关于 Histogen 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Rochelle Fuhrmann 
